It was recently shown that miR-210 upregulation promotes the development of NSCLC by controlling the PI3K/AKT signaling pathway and dwelling on the transcription factor RUNX3 (26) ADDIN. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.